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Abstract
Objective To quantify the hospital burden and health economic impact of idiopathic intracranial hypertension.
Methods Hospital Episode Statistics (HES) national data was extracted between 1st January 2002 and 31st December 2016.
All those within England with a diagnosis of idiopathic intracranial hypertension were included. Those with secondary
causes of raised intracranial pressure such as tumours, hydrocephalus and cerebral venous sinus thrombosis were excluded.
Results A total of 23,182 new IIH cases were diagnosed. Fifty-two percent resided in the most socially deprived areas
(quintiles 1 and 2). Incidence rose between 2002 and 2016 from 2.3 to 4.7 per 100,000 in the general population. Peak
incidence occurred in females aged 25 (15.2 per 100,000). 91.6% were treated medically, 7.6% had a cerebrospinal ﬂuid
diversion procedure, 0.7% underwent bariatric surgery and 0.1% had optic nerve sheath fenestration. Elective caesarean
sections rates were signiﬁcantly higher in IIH (16%) compared to the general population (9%), p < 0.005. Admission rates
rose by 442% between 2002 and 2014, with 38% having repeated admissions in the year following diagnosis. Duration of
hospital admission was 2.7 days (8.8 days for those having CSF diversion procedures). Costs rose from £9.2 to £50 million
per annum over the study period with costs forecasts of £462 million per annum by 2030.
Conclusions IIH incidence is rising (by greater than 100% over the study), highest in areas of social deprivation and
mirroring obesity trends. Re-admissions rates are high and growing yearly. The escalating population and ﬁnancial burden of
IIH has wide reaching implications for the health care system.
Introduction
In light of the growing obesity epidemic, re-evaluation of
trends in idiopathic intracranial hypertension (IIH) are
needed. This would inform the agenda to standarise care
pathways, improve quality of care provision and drive
developments in novel therapeutic options to reduce the
burden of this expanding disease.
IIH is a condition of unknown aetiology which occurs
predominantly in obese women [1, 2]. There are currently
few treatment options for IIH [3], management is typically
medical, with those experiencing progressive visual loss
undergoing surgical procedures [4]. Currently weight loss is
the only disease modiﬁable therapy [5].
IIH was considered a rare condition. Previous annual
incidence was reported at approximately 0.5–2 in 100,000
in the general population [6–12]. Prevalence data is sparse
for the United Kingdom (UK) but a retrospective case
review has reported prevalence of 10.9 per 100,000 for the
general population in Shefﬁeld, UK [6]. It has been widely
speculated that the incidence of IIH is increasing in line
with the world-wide epidemic of obesity [2, 10, 12].
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Despite the relative rarity of IIH the multidisciplinary
manifestations of the condition leads these patients to access
hospital care though a large number of hospital specialties.
In the UK suspected patients attend accident and emergency
departments, are admitted to hospital or have procedures on
ambulatory day care units. The scale of emergency room
attendances, hospital admissions and day case care in the
England has not been previously reported. Previous data
from the United States has highlighted the economic burden
of IIH [13, 14].
This observational study aimed to use Hospital Episode
Statistics (HES) dataset to quantify incidence trends over
time within England. We sought to deﬁne incidence by
geographical distribution and socio-economic deprivation
as well as determine the annual admission rates, manage-
ment strategy (medical vs. surgical) as well as obstetric
outcomes. The secondary aims were to conduct a health
economic evaluation to establish the ﬁnancial impact.
Methods
Study design and setting
This study was conducted through use of registered national
data sets, and included all patients with IIH admitted for
hospital care in England between 1st January 2002 and 31st
December 2016. Data were obtained from the HES, an
administrative dataset covering all NHS Trusts in England,
which processes over 125 million admitted patient, out-
patient and accident and emergency records each year;
generating a log of each clinical episode taking place in
NHS hospitals or NHS commissioned activity in the inde-
pendent sector (private care). Admitted patient care epi-
sodes are deﬁned as emergency room attendances,
ambulatory care attendances (for example for lumbar
puncture) and inpatient care [15].
Each record is anonymised and comprises speciﬁc
demographic details of the admitted patient including age
group, gender, ethnicity and geographical information such
as where patients are treated and the area where they live (it
is worth noting that body mass index data is not recorded).
Data was checked for duplicate patient identiﬁers to ensure
there was no double counting of entries. University Hos-
pitals Birmingham NHS Foundation Trust holds a Data Re-
Use Agreement for the interrogation of the HES. The
research involved non-identiﬁable information, previously
collected in the course of patient care and available for
public use.
To access information pertaining to all IIH admissions,
validated International Classiﬁcation of Diseases, Tenth
Revision, Clinical Modiﬁcation (ICD-10-CM) codes and
procedural classiﬁcations from the Ofﬁce of Population,
Censuses and Surveys Classiﬁcation of Interventions and
Procedures, 4th revision (OPCS-4) codes were used (sup-
plementary ﬁle 1).
Exclusion criteria were applied to help reﬁne the data and
ensure against miscoding of secondary causes of raised
intracranial pressure such as tumours, hydrocephalus and
cerebral venous sinus thrombosis (supplementary ﬁle 1).
Due to the very high number of admitted patient care and
comorbidities, we exclude those with a history of dialysis,
as the high admission rates would have potentially biased
the results.
Data collection
Patient demographics at the time of admitted patient care
episodes were recorded and included gender; ethnicity;
geographical regional location, as classed by the Govern-
ment Ofﬁce Region (GOR); and social deprivation
indices based on the English index of multiple deprivation
(IMD) 2010. The IMD is the ofﬁcial measure of relative
deprivation (for neighbourhoods) in England and has been
used frequently as a measure of relative deprivation to
guide resource allocation and provision of services in the
United Kingdom. Deprivation in this context refers to the
relative disadvantage an individual experience living in a
certain area. The IMD is based on 38 routinely collected
indicators, aggregated into seven weighted domains to
represent different dimensions of deprivation, namely
income, employment, health and disability, education and
skills, barriers to housing and services, crime and
environment.
The IMD uses an area-based model at a low geography
(average of 1500 people). Ranking the areas from 1 (most
deprived area) to 32,844 (least deprived area) and quintiles
are calculated dividing the ranking into ﬁve equal groups
[16].
World Health Organisation (WHO) obesity data, only
available up to 2014, was used to estimate UK obesity
trends. Obesity is classed as a body mass index (BMI) ≥ 30
and is age-standardized in18 years+ by gender in the UK.
National rates of obesity from Health survey for England
2015, were used for correlation of obesity rates per depri-
vation quintiles [17].
Visual complications and related surgical treatments,
including cerebrospinal ﬂuid diversion procedures, optic
nerve sheath decompression and bariatric surgery, were
recorded in this cohort. Cerebral venous stenting was
initially scoped, but the multiple codes used to deﬁne one
procedure varied greatly, and the data here would have been
inconsistent and inaccurate. To investigate women’s health
through pregnancy outcomes, the IIH cohort was matched
against HES data from the general population for number of
live births and mode of delivery.
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Economic model methods
To estimate the direct health care costs of IIH, a patient
pathway model was developed based on the HES data
presented here, and the Cambridge shunt registry [18]. Only
direct health care resources associated with the diagnosis
and treatment of IIH were included and no costs relating to
the wider economy (such as days lost to work, childcare
costs or travel to hospital) were calculated. The cost data
applied to the health care resource use was taken from
Optom [19], 2015–16 NHS reference costs [20] and the
British National Formulary [21] (supplementary ﬁle 2).
The pathway model was developed to illustrate each step
of the patient pathway for the ﬁrst year and tree diagrams
were constructed (supplementary ﬁles 3,4). In addition to
those already cited, to predict future costs other sources
were utilised [22, 23] (supplementary ﬁle 5).
Statistical analysis
The data were initially explored through descriptive ana-
lysis of variables using t tests for quantitative variables and
a χ2 test for categorical variables to compare different
groups. Incidence and obesity data were normally dis-
tributed and pearson correlations were utilized. All statis-
tical analyses were conducted using GraphPad PrismTM
(version 7.04).
Results
HES identiﬁed 26,565 unique patients coded with IIH
(ICD10=G932) between 1/1/2002 and 31/12/2016. To
ensure that an unbiased representative population was
analysed 3383 were excluded from the analysis (Fig. 1).
The number of individual patients diagnosed with IIH
was 23,182 during the study period (Fig. 2). 17.6% (4079/
23,182) were male and 82.4% (19103/23,182) were female.
The median age at diagnosis was 28 years (range: 21–40
years) (Fig. 2b; supplementary ﬁle 6).
With males having a higher median age of 32 years
(range 14–50 years) and women a lower median age of 28
years (range: 22–38 years) (Fig. 2b). The majority of the
ethnic groups reﬂected the population of England, with
white being the prominent category in IIH (supplementary
ﬁle 7).
Incidence of IIH
In the general population, the incidence of IIH increased by
108% over the study period; in 2002 it was 2.26 per
100,000 rising to 4.69 per 100,000 in 2016 (Fig. 2a).
Overall the peak incidence was seen in females aged 25
years and was 15.2 per 100,000 (Fig. 2b). The incidence in
females in 2002 was 3.53 per 100,000 rising to 7.69 per
100,000 with the rates increasing in line with obesity in
females (r= 0.914, P < 0.0001) and also in males (0.9 per
100,000 to 1.6 per 100,000, r= 0.913, p < 0.0001)
(Fig. 2c). This represents a 118% increase in incidence in
females.
IIH incidence varied with geographical region across the
UK with greater incidence noted in the East of England
and the West Midlands (supplementary ﬁle 8, Figs. 2e, f).
Cases of IIH varied with social deprivation (Fig. 3). Fewer
cases are recorded in least deprived areas (deprivation
quintile 5, 3080 (13.3%) cases of IIH). Whilst in areas of
higher deprivation (deprivation quintiles 1 and 2) the
majority of IIH cases were recorded (12,136 cases, 52.3%)
(Fig. 3a).
Fig. 1 Consort diagram
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The relationship between IIH and social deprivation
varied with gender, with female cases signiﬁcantly corre-
lating with deprivation r= 0.89, p < 0.001, but this was not
apparent in male cases (r= 0.37, p= 0.539) (Fig. 3a).
BMI is known to differ with deprivation quintiles [17], and
here amongst the female IIH population, cases correlated
with deprivation quintile BMI (r= 0.98, p= 0.003),
however male gender did not (r= 0.59, p= 0.291)
(Fig. 3a).
Admitted hospital episodes
Between 2002 and 2014 there were 47,982 hospital
admitted patient care (emergency room attendances,
admitted inpatient episodes and ambulatory care episodes)
for IIH (Fig. 3b) for 23,182 patients. Over the study period
there was an increase in admitted hospital episodes for IIH
by 442% (1315 to 7123 patients admitted per year over the
study period). Over half of the cohort had only one
Fig. 2 Composite ﬁgure. a
Incidence in the general
population. b Incidence by age
and gender. c Annual incidence
in females and males and
Obesity rates (% obesity per
annum (body mass index ≥ 30),
age-standardized in 18 years+
by gender in the United
Kingdom. From World Health
organisation http://apps.who.int/
gho/data/node.main.A900A?la
ng=en Accessed 6 Oct 2017. d
Management of IIH in the
cohort. e Geographical
distribution of diagnosed cases
of IIH in England. f Distribution
of cases by region per annum
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admission episode and no further admitted hospital care in
the year following the diagnostic episode coded for IIH.
37.8% of the cohort had repeat hospital admissions in the
ﬁrst year following their diagnosis (supplementary ﬁle 9),
with 0.9% having 10 or more admitted hospital episodes.
The average length of stay was 2.7 days, for those who
had no surgical procedure, and for those who undergo
neurosurgical management was 8.8 days. Over the study
period, the majority were managed medically (91.6%);
7.64% (1771/23,182) had a shunt procedure; 0.68% (158/
23,182) underwent bariatric surgery; and 0.07% (10/23,182)
had an optic nerve sheath fenestration (Fig. 2d).
Morbidity
Following diagnosis of IIH, according to HES records, 99
were coded as blind and 349 as visually impaired. There-
fore, any type of visual impairment following a diagnosis of
IIH is seen in 1.92% (445/23,182) of the cohort (with 0.42%
being blind and 1.49% being visually impaired).
Obstetric health
Those women between 16 and 55 years with IIH had similar
birth rates to those in the general population of the same age
range (supplementary ﬁle 10). IIH women were statistically
less likely to have a normal delivery compared to age
matched women in the general population with 4839
(57.44%) of women with IIH having a normal delivery
compared to 3,612,199 (64.09%) in the general population,
p < 0.005. Women with IIH were signiﬁcantly more likely
to undergo elective (n= 1328) and non-elective caesarean
sections (n= 1427) compared to the general population
(elective n= 514,287; non-elective n= 960,394), p < 0.005.
Economic estimate
IIH was estimated to represent an annual hospital healthcare
cost of £7016 per patient. When combined with the IIH
population incidence rates, the total cost of IIH hospital care
has risen dramatically from £9.2 million in 2002 to £49.9
million in 2014 (Fig. 3c). A prediction of future economic
hospital burden was based on the current cost estimation
and the expected population trends: if the rising trends of
IIH continue then by 2030 it is projected to cost hospitals in
England £462.7 million (Fig. 3d).
Discussion
In this observational study of HES data the increase in IIH
incidence by 108% is described. Of note the rising
Fig. 3 a IIH cases according to gender and socioeconomic status (solid
line). % obesity rates (body mass index ≥ 30), age-standardised (aged
> 16) by equivalised household income and sex (dotted line), data
from Health Survey for England 2016. b Annual hospital episodes for
IIH. c Hospital costs per annum for IIH. d Future predicted costs in
millions (£) of IIH in England based on current trends
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incidence signiﬁcantly correlates with rising BMI in both
genders, which has been previously speculated [4]. The
incidence in women is four fold higher than in males (7.7
women vs. 1.6 per 100,000 male), with a peak incidence in
women at the age of 25 years (15.2 per 100,000). Adult IIH
has not been previously associated with social deprivation
and adverse obstetric outcomes. These factors are new
signals which reinforce that this disease should not be
assumed “benign”.
Over half of the cohort was recorded in the lowest two
quintiles of the IMD. Deprivation and social determinants
are well known to cause a wide range of adverse health
effects and are associated with higher morbidity and mor-
tality [24, 25]. Area deprivation, as measured utilizing IMD,
is an aggregated marker of social deprivation [25]. It is
reliably used and has been associated with poorer clinical
outcomes [26] and an increased number of co-morbidities
[27, 28]. We have shown that IIH cases are signiﬁcantly
associated with deprivation quintile speciﬁc BMI rates
(Fig. 3a) and we hypothesise that increased BMI may be a
predominant factor in determining the variable in IIH social
deprivation.
Over a third of the cohort had multiple hospital admis-
sions (emergency room, inpatient or ambulatory care epi-
sodes) within the ﬁrst year following diagnosis (Table 1); a
442% increase in admissions in the period studied. Depri-
vation status has been found to strongly inﬂuence admission
and readmission rates for medical patients [29]. Primary
care and unplanned hospital services are accessed more by
those in deprived areas than those who are not [30] and
those from deprived areas are less likely to visit a secondary
care specialist [31]. National consensus guidelines could
potentially help to reduce these attendances [32].
A prevalence study [33] reported 1–2% severe visual loss
in IIH within the UK. The visual loss rates reported here are
1.92% of this English cohort, with 0.42% being blind and
1.49% with any kind of visual impairment. These rates may
be an underestimation due to the differences in the deﬁni-
tions of visual impairment between the coding in HES and
national deﬁnitions for certiﬁcate of visual impairment
(supplementary ﬁle 1) [34]; and potentially represent
underreporting of comorbidities in the HES data. Linkage of
the HES and the certiﬁcate of visual impairment register
was not possible with this anonymized study design.
The major strength of this study is that the analysis
covers all IIH patients admitted hospital episodes in English
NHS and private hospitals over a 14 year period and is
therefore a unique population-wide assessment. Using
national data over a long time-period allows for variation
across the years. Unlike insurance company data our data is
unlikely to be biased due to variation in funding between
hospitals, insurance coverage or the patients’ ability to pay
for care. However, like any database improvements in
clinical record keeping and hence coding will improve the
accuracy of the data. Likewise, we cannot be sure each of
the individuals fulﬁlled the diagnostic criteria for IIH, and
are dependant on the medical staff to make accurate diag-
noses [1]. Changes in awareness of the condition and the
medical literature, such as publication of revised diagnostic
criteria [1], could have inﬂated the incidence following
publication. Within the results there is a portion of patients
diagnosed over the age of 65 years (supplementary
Table 5), these cases likely represent misdiagnosis of phe-
notypical IIH, as the natural history of the disease is within
the younger age ranges [2, 4].
Obstetric health is important in IIH, as the majority are
women of child-bearing age (Fig. 2b). Literature in this area
is case based [35]. Although those with IIH have similar
parity compared to the general population (supplementary
ﬁle 10) they were signiﬁcantly more likely to undergo both
elective and non-elective caesarean sections compared to
the general population. This may be due to the association
of obesity, as higher rates of caesarean section are reported
in overweight and obese individuals [36]. Practical gui-
dance in IIH does not suggest opting for caesarean section
based solely on the diagnosis of IIH and as the transient
elevations in ICP during the second stage of labour are
unlikely to impact on the optic nerve function, except in the
setting of fulminant IIH [32].
IIH is considered rare, however the rising incidence,
hospital episodes and subsequent economic impact are
noteworthy with wide reaching implications for health care
service provision. The consensus guidelines [32] will
start to shape and standardised care pathways and improve
the quality of care. Development of novel therapeutic
options may help to reduce the burden of this expanding
disease.
Summary
What was known before
● Previous annual incidence was reported at approxi-
mately 0.5–2 in 100,000 in the general population.
● It has been widely speculated that the incidence of IIH is
increasing in line with the world-wide epidemic of
obesity.
● No previous studies have determined IIH as a disease
predominantly associated with social deprivation.
What this study adds
● In this study of 23,182 IIH patients incidence is rising
(4.69 per 100,000 in 2016) and this in line with
increasing body mass index rates.
S. P. Mollan et al.
● IIH is more commonly found in those from areas of
social deprivation.
● The hospital economic burden has risen from 9.2 million
in 2002 to 49.9 million in 2014.
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